Alignment Healthcare Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $4.6B+69.3% YoYTTM through 30 Jun 2026
Net Income $40.7MTTM through 30 Jun 2026
Free Cash Flow $177.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 12.5% |
| EBITDA Margin | 1.9% |
| Operating Margin | -0.4% |
| Net Margin | 0.9% |
Returns
15.4%ROE
3.2%ROA
-39.0%ROIC
Balance Sheet Health
Debt / Equity1.80x
Current Ratio1.71x
Net Debt-$281.1Mnet cash position
Cash & Equivalents$693.5M
Quality Metrics
Altman Z-Score4.10
Piotroski F-Score7 / 9
FCF Margin3.9%
Rule of 4017.8
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $3.9B
Diluted EPS$0.19TTMFY2025: $0.00
Dividend
No dividend
Capital Allocation
Capex Intensity0.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Medicare Advantage | $3.9B | +46.1% | View detailsIntroduced 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30% to 31% growth year-over-year. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.